The committee's first vote, on BPC-157, came out in favor of widening access to the peptide
Tesamorelin Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH)
Q: What is the advantage of compounded hair loss formulations over commercial products
Three years ago, the FDA determined that certain peptides should not be compounded, citing significant safety concerns, including the risk of life-threatening allergic reactions
Recalls & Warnings December 08, 2020 FTC Sends Refund Checks to Consumers of Deceptive Joint Pain Supplement Synovia On December 1, 2020, the FTC announced it is mailing 13,221 checks totaling nearly $775,000 to consumers who bought Synovia, a supplement intended to treat joint pain and arthritis
In the Spotlight : Why Does the Prohibited List Matter